Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 3,684,800 | 3,399,300 | 3,027,299 | 3,469,500 | 3,628,700 |
| Cost of Goods | 441,500 | 477,400 | 103,600 | 710,300 | 917,800 |
| Gross Profit | 3,243,300 | 2,921,900 | 2,923,700 | 2,759,200 | 2,710,900 |
| Operating Expenses | 3,766,600 | 3,097,200 | 3,524,100 | 4,136,900 | 3,187,800 |
| Operating Income | -487,600 | -171,500 | -599,800 | -1,377,400 | -476,100 |
| Interest Expense | 345,800 | 332,800 | 341,300 | 340,200 | 339,900 |
| Other Income | 152,600 | 3,400 | 7,000 | 3,700 | -37,800 |
| Pre-tax Income | -680,800 | -500,900 | -934,100 | -1,713,900 | -853,800 |
| Income Tax | -258,200 | -408,700 | -126,100 | -838,900 | -381,900 |
| Net Income Continuous | -422,600 | -92,200 | -808,000 | -875,000 | -471,900 |
| Net Income Discontinuous | -77,300 | 348,600 | 178,700 | 6,177,600 | 230,300 |
| Minority Interests | 1,800 | 700 | 1,600 | 1,400 | 1,500 |
| Net Income | $-501,700 | $255,700 | $-630,900 | $5,301,200 | $-243,100 |
| EPS Basic Total Ops | -1.44 | 0.47 | -0.63 | 13.29 | -0.80 |
| EPS Basic Continuous Ops | -1.25 | -0.41 | -2.06 | -2.40 | -1.38 |
| EPS Basic Discontinuous Ops | -0.19 | 0.88 | 1.43 | 15.69 | 0.58 |
| EPS Diluted Total Ops | -1.44 | 0.47 | -0.63 | 13.29 | -0.80 |
| EPS Diluted Continuous Ops | -1.25 | -0.41 | -2.06 | -2.40 | -1.38 |
| EPS Diluted Discontinuous Ops | -0.19 | 0.88 | 1.43 | 15.69 | 0.58 |
| EBITDA(a) | $1,158,500 | $1,511,700 | $1,201,000 | $590,299 | $1,749,300 |